Salvage Chemotherapy With Paclitaxel, Vinorelbine, and Cisplatin (PVC) in Anthracycline-Resistant Advanced Breast Cancer

The tolerance and the efficacy of the paclitaxel-vinorelbine-cisplatin combination (PVC regimen) was evaluated in 33 patients with anthracycline-resistant stage IV breast cancer, who had disease progression under anthracyclineor mitoxantrone-based chemotherapy. Fourteen (42%) and 19 (58%) patients h